Oncogenic nature of a novel mutant AATF and its interactome existing within human cancer cells

Shaveta Sharma1, Deepak Kaul, Mansi Arora

  • 1Department of Experimental Medicine & Biotechnology, Molecular Biology Unit, Post-graduate Institute of Medical Education & Research, Chandigarh, 160012, India.

Cell Biology International
|September 19, 2014
PubMed

Insights

The anti-apoptotic factor AATF/Che-1 acts as an

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Epigenetics

Background:

  • Apoptosis is a natural defense against cancer development.
  • The anti-apoptotic factor AATF/Che-1 is identified as a key 'Epigenomic-Switch'.

Purpose of the Study:

  • To investigate the dual role of AATF/Che-1 in cancer.
  • To characterize the aberrant AATF/Che-1 transcriptome and its protein product in human cancer cells.

Main Methods:

  • Analysis of aberrant AATF/Che-1 transcriptome.
  • Identification of the mutant AATF protein interactome in various human cancer cells.
  • Investigation of DNA methylation patterns associated with the mutant AATF interactome.

Main Results:

  • Discovery of a 23 kDa mutant AATF protein arising from an aberrant transcriptome.
  • Identification of a unique interactome for mutant AATF, including SP1, DNMT3B, and Par-4.
  • Demonstration that the mutant AATF interactome promotes DNA methylation, leading to tumor suppressor gene downregulation.

Conclusions:

  • The mutant AATF interactome establishes and maintains a cancerous phenotype in human cells.
  • This pathway highlights a novel mechanism by which cancer cells evade apoptosis and promote tumorigenesis.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K